Environmental Dermatology

Botanical Briefs: Primula obconica Dermatitis

Author and Disclosure Information

 

References

Cultivating the plant outdoors during the winter in milder climates can potentially decrease sensitivity because allergen production is lowest during cold months and highest during summer.11 Because P obconica is commonly grown indoors, allergenicity can persist year-round.

Pharmacotherapy—Drawing on experience treating CD caused by other plants, acute and chronic P obconica CD are primarily treated with a topical steroid or, if the face or genitals are affected, with a steroid-sparing agent, such as tacrolimus.12 A cool compress of water, saline, or Burow solution (aluminum acetate in water) can help decrease acute inflammation, especially in the setting of vesiculation.13

Mild CD also can be treated with a barrier cream and lipid-rich moisturizer. Their effectiveness likely is due to increased hydration and aiding impaired skin-barrier repair.14

Some success in treating chronic CD also has been reported with psoralen plus UVA and UVB light therapy, which function as local immunosuppressants, thus decreasing inflammation.15

Final Thoughts

Contact dermatitis caused by P obconica is common in Europe but less common in the United States and therefore often is underrecognized. Avoiding contact with the plant should be strongly recommended to allergic persons. Primula obconica allergic CD can be treated with a topical steroid.

Pages

Recommended Reading

Hairdressers have ‘excess risk’ of contact allergies
MDedge Dermatology
Botanical Briefs: Toxicodendron Dermatitis
MDedge Dermatology
Breaking the itch-scratch cycle with mindfulness
MDedge Dermatology
Higher metal contact allergy rates found in metalworkers
MDedge Dermatology
Botanical Briefs: Daffodils (Narcissus Species)
MDedge Dermatology
Cutaneous Manifestations in Hereditary Alpha Tryptasemia
MDedge Dermatology
Use of Dupilumab in Severe, Multifactorial, Chronic Itch for Geriatric Patients
MDedge Dermatology
Janus Kinase Inhibitors: A Promising Therapeutic Option for Allergic Contact Dermatitis
MDedge Dermatology
Isothiazolinone contact allergy up in North America, down in Europe
MDedge Dermatology
Can skin care aid use of diabetes devices?
MDedge Dermatology